Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Certain bacteria from the Citrullus colocynthis plant may be a new source of antibiotics to fight drug-resistant diseases.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Minoxidil's absorption is too variable for it to be a reliable reference drug.

Treating hair loss in both men and women is effective and improves quality of life.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Premature hair graying is caused by genetics, stress, and lifestyle, and affects mental health.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Egyptian researchers are advancing in pharmaceutical nanotechnology, potentially improving health outcomes and the economy.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Individualized treatments may help manage Dercum's disease symptoms.

The new delivery system could improve pain and inflammation relief in gout.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Invasomes with 0.5% limonene greatly improve skin delivery of finasteride.

Finasteride in lipid carriers improved hair growth in rats.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.